Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03709043 · ClinicalTrials.gov registry record · Phase 2
Addressing Heavy Alcohol Use Consumption With Kudzu
A Phase 2 study of Alcohol Use Disorder and Sexually Transmitted Diseases, sponsored by Glenn-Milo Santos.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT03709043 is a Phase 2 study of Alcohol Use Disorder and Sexually Transmitted Diseases that has completed, run by Glenn-Milo Santos. The registered enrollment target is 120 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03709043, a Phase 2 study of Alcohol Use Disorder and Sexually Transmitted Diseases, has completed, sponsored by Glenn-Milo Santos.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Drinking multiple alcoholic drinks on a single occasion (binge drinking), has many negative health risks but interventions to address this behavior remain limited. This double-blind, placebo-controlled randomized clinical trial will test whether kudzu, an herbal supplement, can reduce heavy alcohol use and alcohol-associated sexual behaviors among sexually-active, binge-drinking individuals at high risk for HIV infection.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Standardized kudzu
- DIAGNOSTIC_TEST Sexually transmitted infection testing:
- BEHAVIORAL Medical Management (MM) counseling for alcohol use:
- DIAGNOSTIC_TEST Urinalysis for novel alcohol biochemical markers for recent alcohol use:
Study Locations (1)
California
- San Francisco Department of Public Health - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-07-11 |
| Est. Completion | 2024-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03709043
The ClinicalTrials.gov registry entry for NCT03709043 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (63% lower). The listed sponsor is Glenn-Milo Santos, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.
NCT03709043 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03709043 about?
NCT03709043 is a clinical study titled "Addressing Heavy Alcohol Use Consumption With Kudzu". Drinking multiple alcoholic drinks on a single occasion (binge drinking), has many negative health risks but interventions to address this behavior remain limited. This double-blind, placebo-controlled randomized clinical trial will test whether kudzu, an herbal supplement, can reduce heavy alcohol ...
What is the current status of trial NCT03709043?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2019-07-11. Estimated completion is 2024-06-01.
What conditions does trial NCT03709043 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Sexually Transmitted Diseases.
What interventions are being tested in trial NCT03709043?
The interventions under investigation include: Placebo (OTHER), Standardized kudzu (DRUG), Sexually transmitted infection testing: (DIAGNOSTIC_TEST), Medical Management (MM) counseling for alcohol use: (BEHAVIORAL), Urinalysis for novel alcohol biochemical markers for recent alcohol use: (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03709043?
This trial is sponsored by Glenn-Milo Santos, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03709043 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
RECRUITING · Phase 2
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
Cannabis' Impact on Alcohol Consumption
RECRUITING · Phase 2
-
COMT Inhibition Among Individuals With Comorbid AUD/ADHD
RECRUITING · Phase 2
-
Semaglutide Therapy for Alcohol Reduction (STAR)
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.